Search Results
1,059 results
Your search is now limited to «Prostate Cancer» expert search.
PF4V1, an miRNA-875-3p target, suppresses cell proliferation, migration, and invasion in prostate cancer and serves as a potential prognostic biomarker Dongyang Li,1 Xuanyu Hao,2 Yudi Dong,3 Mo Zhang,1 Yongsheng Song1 1Department of Urology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China; 2Department of Rheumatology and Immunology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People’s Republic of China; 3Laboratory of Experimental Oncology, Medical Research Center, Shengjing Hospital of China Medical University, Benxi, Liaoning, People’s Republic of China Background: PF4V1 is a novel protein in inflammation, angiogenesis, and cancer.
More from International Journal of COPD:
MedPageToday.com 03/20/2019 14:00
The retrospective study drew on the records of patients receiving CIRT for prostate cancer from June 1995 to July 2012 at the NIRS, and from control cohorts of prostate cancer patients receiving photon RT or surgery in the Osaka Cancer registry from January 1994 to December 2012.
More from MedPageToday.com:
Abstract Histologic transformation to small cell neuroendocrine prostate cancer occurs in a subset of patients with advanced prostate cancer as a mechanism of treatment resistance.
More from Science Translational Medicine:
In addition to fundraising for research programs, PCF increases awareness of prostate cancer and lobbies for government research funds for prostate cancer research.
More from Global Banking & Finance Review:
PR Newswire 03/20/2019 08:00
To obtain this licensure to serve the approximately 5,000 men in New York with advanced prostate cancer, Epic Sciences submitted to NYSDOH a robust dossier of data published in JAMA Oncology establishing the predictive benefit of the test, in addition to analytical performance data demonstrating the quality of the test.
More from PR Newswire:
ecancer news 03/20/2019 06:09
This form is challenging to treat, which is one of the reasons prostate cancer is the second-leading cause of cancer deaths in men.
More from ecancer news:
GlobeNewswire 03/20/2019 05:27
The aim of the study was to investigate the diagnostic value of the AroCell TK 210 ELISA together with free PSA, pro PSA and PHI in differentiating prostate cancer from benign urological conditions.
More from GlobeNewswire:
PubMed News (NIH) 03/20/2019
Contributors : Daniel J Coleman ; Lina Gao ; Carly J King ; Jacob Schwartzman ; Joshua Urrutia ; Archana Sehrawat ; Junior Tayou ; Ariel Balter ; Julja Burchard ; Kami E Chiotti ; Laura M Heiser ; Joshi J Alumkal Series Type : Expression profiling by high throughput sequencing ; Genome binding/occupancy profiling by high throughput sequencing Organism : Homo sapiens. BET bromodomain inhibitors are known to block prostate cancer cell survival through suppression of c-Myc and androgen receptor (AR) function.
More from PubMed News (NIH):
DoctorsLounge 03/19/2019 15:00
The new study found that men on hormone-reducing therapy after having their prostate removed were 80 percent more likely to develop depression than other prostate cancer patients.
More from DoctorsLounge:
Other awards were given, followed by an emotional “raising of the blue lights” by everyone as entertainer Jimmy Charles sang the inspiring words of his anti-prostate cancer song, Superman which shares the words “You can’t fight this battle on your own.
More from ZERO – The End of Prostate Cancer:
ClinicalTrials.gov 03/19/2019 09:24
However, patients often have lots concerns while deciding whether or not to undergo a prostate biopsy.
More from ClinicalTrials.gov:
FeedNavigator 03/19/2019 08:57
Acta Oncol. 2019 Mar 18:1-10. doi: 10.1080/0284186X.2019.1581373. [Epub ahead of print]
More from FeedNavigator:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications